R10061 |
Nexavar; Bay 43-9006; Sorafenib |
Sorafenib Tosylate is a multikinase inhibitor of Raf-1, B-Raf and VEGFR-2 with I
|
R10062 |
SAR131675 |
SAR131675 is a VEGFR3 inhibitor with IC50/Ki of 23 nM/12 nM in cell-free assays,
|
R10064 |
Brivanib; BMS540215 |
Brivanib is an ATP-competitive inhibitor against VEGFR2 with IC50 of 25 nM, mode
|
R10118 |
Regorafenib; BAY73-4506; BAY734506 |
Regorafenib (BAY 73-4506) is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3
|
R10151 |
E7080; Lenvatinib |
Lenvatinib (E7080) is a multi-target inhibitor, mostly for VEGFR2(KDR)/VEGFR3(Fl
|
R10192 |
ZM323881HCl |
ZM 323881 is a potent and selective VEGFR2 inhibitor with IC50 of <2 nM, almo
|
R10193 |
ZM 306416 (Synonyms: CB 676475) |
ZM 306416 is a VEGFR (Flt and KDR) inhibitor for VEGFR1 with IC50 of 0.33 μM, bu
|
R10255 |
LY2874455; dovitinib |
LY2874455 is a pan-FGFR inhibitor with IC50 of 2.8 nM, 2.6 nM, 6.4 nM, and 6 nM
|
R10283 |
Nintedanib esylate; BIBF1120 esylate |
Nintedanib (BIBF 1120) is a potent triple angiokinase inhibitor for VEGFR1/2/3,
|
R10331 |
Cabozantinib S-malate (XL184 S-malate; BMS-907351 S-malate) |
abozantinib malate (XL184) is the malate of Cabozantinib, a potent VEGFR2 inhibi
|
R10540 |
Regorafenib monohydrate |
Regorafenib is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3, PDGFR??, Kit
|
R10545 |
CANGRELOR |
Regorafenib is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3, PDGFR, Kit,
|
R10733 |
Semaxinib;SU5416 |
Semaxanib (SU5416) is a potent and selective VEGFR(Flk-1/KDR) inhibitor with IC5
|
R11552 |
BFH-772 |
BFH772 is a novel potent oral VEGFR2 inhibitor, targeting VEGFR2 kinase with IC5
|